Nevertheless, the associations between the PLCG2 and TREM2 loci and putamen/globus pallidus broadly suggest that the volumetric reductions in basal ganglia may reflect a immunogenic mechanism of AD-linked susceptibility that manifests in early life process and a potential target for detection, prevention, and intervention. This evidence concerns the gene TREM2 and Alzheimer disease.